Key result
Revised Geneva Score effectively stratifies suspected PE into low, intermediate, and high probability groups.
Why the study?
The Revised Geneva Score was derived to provide a completely objective clinical decision rule for suspected pulmonary embolism.
Does the Revised Geneva Score accurately estimate the pre-test probability of pulmonary embolism in patients with suspected PE?
Does the Revised Geneva Score accurately estimate the pre-test probability of pulmonary embolism in patients with suspected PE?
Answers are grounded in this paper and cite their sources.
The Revised Geneva Score is a validated, objective clinical prediction rule for stratifying the pre-test probability of pulmonary embolism.
The Revised Geneva Score was derived to provide a completely objective clinical decision rule for suspected PE. In the derivation study (Le Gal et al., 2006), the score stratified patients into three probability groups: low (8% prevalence), intermediate (28%), and high (74%). The revised Geneva score is a validated clinical prediction rule for estimating the pre-test probability of pulmonary embolism (PE) in patients with suspected PE
No takes yet. Share an insight, caveat, or question.
Riddhi Desai (2026) conducted a review in Suspected pulmonary embolism (PE). Revised Geneva Score was evaluated on Pre-test probability of pulmonary embolism. The Revised Geneva Score is a validated clinical prediction rule that stratifies patients with suspected pulmonary embolism into low, intermediate, and high probability groups.
Synapse has enriched 10 related papers. Consider them for comparative context: